Louvenia D Barksdale Sickle Cell Anemia Foundation Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 113,636 | 155,336 | −41,700 | 9.1 | 54% |
| 2012 | 133,240 | 126,065 | 7,175 | 11.9 | 52% |
| 2013 | 175,424 | 154,540 | 20,884 | 0.6 | 53% |
| 2014 | 139,808 | 146,569 | −6,761 | 0.1 | 43% |
| 2015 | 194,156 | 167,932 | 26,224 | 2.0 | 42% |
| 2016 | 119,322 | 117,853 | 1,469 | 2.5 | 52% |
| 2017 | 151,660 | 143,857 | 7,803 | 2.0 | 31% |
| 2018 | 171,820 | 169,470 | 2,350 | 1.7 | 41% |
| 2019 | 176,237 | 160,846 | 15,391 | 1.1 | 65% |
| 2020 | 120,887 | 138,226 | −17,339 | 0.1 | 59% |
| 2021 | 207,334 | 196,071 | 11,263 | 0.7 | 49% |
| 2022 | 678,100 | 673,572 | 4,528 | 0.3 | 15% |
| 2023 | 621,098 | 494,708 | 126,390 | 3.5 | 41% |
In its most recent public year (2023), this organization brought in $126,390 more than it spent. Its reserves stood at about 3.5 months of spending, down from 9.1 in 2011. Staff pay was 41% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Louvenia D Barksdale Sickle Cell Anemia Foundation Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works